Articles From: Legg Mason Reports Assets Under Management For April 2014 to Caribbean International Holdings (CIHN), Announces Site of 2nd International Treatment Facility; Facility is Approved for Stem Cell Therapies by Mexico's Equivalent of US FDA


2014/5/12
BALTIMORE , May 12, 2014 /PRNewswire/ -- Legg Mason , Inc. (NYSE: LM) reported preliminary assets under management of $673 billion as of April 30 , 2014.
Sign-up for Legg Mason Reports Assets Under Management For April 2014 investment picks
Recommends Stockholders Vote Revised White Proxy Card PHILADELPHIA , May 12, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE) , a medical device company developing its Symphony ® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it has filed its definitive proxy materials with the Securities and Exchange Commission in connection with its 2014 Annual Meeting of Stockholders to be held on Thursday, June 19, 2014 , at 10:00 a.m. EDT , at Echo's offices located at 10 Forge Parkway, Franklin, Massachusetts 02038.
Sign-up for Echo Therapeutics Files Definitive Proxy Materials investment picks
2014/5/12
Note: All figures are quoted in U.S. dollars unless otherwise noted.
Sign-up for Ivanhoe Energy Reports First Quarter 2014 Financial Results investment picks
SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that William Lis, chief executive officer, will present at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas on Thursday, May 15, 2014, at 10:00 a.m. Pacific Time.
Sign-up for Portola Pharmaceuticals to Present at Bank of America Merrill Lynch 2014 Health Care Conference investment picks
http://media.marketwire.com/attachments/201405/TN-75154_board.jpg SMART kapp, dry-erase board replacement, launches at InfoComm, June 18-20 http://media.marketwire.com/attachments/201405/247840_SMARTlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1114416&ProfileId=051205&sourceType=1 CALGARY, AB --
Sign-up for SMART Revolutionizes the Dry Erase Board With SMART kapp (TM) investment picks
NEW YORK (MarketWatch) -- The U.S. Food and Drug Administration has approved a new drug by Merck (MRK) that lowers the risk of heart attacks and cardiovascular events associated with peripheral arterial disease.
Sign-up for FDA approves Merck's heart-attack prevention drug investment picks
2014/5/12
By Quentin Fottrell 1.
Sign-up for UPDATE: 10 things CEOs won't tell you investment picks
2014/5/12
-Quentin Fottrell; 415-439-6400; AskNewswires@dowjones.com 7.
Sign-up for UPDATE: 10 things CEOs won't tell you -2- investment picks
2014/5/12
http://media.marketwire.com/attachments/201405/TN-247797_TASERInernationalHQScottsdaleAZUS.jpg TASER's HQ in Scottsdale, AZ.
Sign-up for TASER International Authorizes Stock Buy-Back Program for up to $30 Million of Company Stock investment picks
BLAINE, Wash., May 12, 2014 (GLOBE NEWSWIRE) -- Mobetize Corp.
Sign-up for Mobetize Corp. to Participate in International Telecoms Week 2014 investment picks
QUÉBEC CITY, May 12, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announces that following its annual meeting of shareholders held on May 9, 2014 , its Board of Directors has appointed current President and CEO, David Dodd , as Chairman of the Board, a decision that is in keeping with Aeterna Zentaris' new strategy of transitioning from a research and development into a commercial company.
Sign-up for Aeterna Zentaris Announces Board of Directors Leadership Change and Election of Directors at Annual Meeting of Shareholders investment picks
http://media.marketwire.com/attachments/201403/72516_flamel.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1114293&ProfileId=051205&sourceType=1 LYON, FRANCE --
Sign-up for Flamel Technologies Announces First Quarter of Fiscal Year 2014 Results investment picks
2014/5/12
Provides Guidance of Revenue and Net Income for the Fourth Quarter of Fiscal Year 2014, and Updates Guidance of Revenue and Net Income for Fiscal Year 2014 XI'AN, China, May 12, 2014 /PRNewswire-FirstCall/ -- Third Quarter of FY 2014 net sales increased 6.7% to $70.3 million; net income decreased 46.2% to $7.2million with EPS of $0.23. The Company Provided Fourth Quarter of Fiscal Year 2014 Guidance Range: Revenue, Net Income and EPS of between $60 million and $70 million , $6 million and $7 million , and $0.19 and $ 0.22 based on 31.8 million numbers of fully diluted shares, respectively.
Sign-up for China Green Agriculture, Inc. Reports the Financial Results for the Third Quarter of Fiscal Year 2014 investment picks
Product is being developed to treat pain in dogs with osteoarthritis KANSAS CITY, Kan.
Sign-up for Aratana Therapeutics Initiates Pivotal Study for AT-001 investment picks
THOUSAND OAKS, Calif.
Sign-up for Ceres Awarded Patent for Innovation in Corn investment picks
- Revenue Increased 236.5% Year-Over-Year to 152.3 Million - - Generated Net Income of $23.6 Million Compared to a Net Loss of $0.6 Million a Year Ago - BEIJING , May 12, 2014 /PRNewswire-FirstCall/ -- Yongye International, Inc. (NASDAQ: YONG) ("Yongye" or the "Company"), a leading developer, manufacturer, and distributor of crop nutrient products in the People's Republic of China ("PRC"), today announced its financial results for the quarter ended March 31, 2014 .
Sign-up for Yongye International Announces First Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G015569-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/5/9/11G015569/Balmoral_Resources_logo-91259228495.jpg http://www.marketwire.com/library/MwGo/2014/5/9/11G015569/Images/Figure_1_Cross_Section_1_62_N-260467776734.jpg Figure 1 - Cross Section 1+62.5 North http://www.marketwire.com/library/MwGo/2014/5/9/11G015569/Images/Figure_2_Plan_Map-1024694265680.jpg Figure 2 - Plan Map http://www.marketwire.com/library/MwGo/2014/5/9/11G015569/Images/Figure_3_Cross_Section_3_25_N-58657577560.jpg Figure 3 - Cross Section 3+25 South VANCOUVER, BC--(Marketwired - May 12, 2014) - Balmoral Resources Ltd.
Sign-up for Balmoral Intersects 1,138 g/t (33 oz/ton) Gold Over 4.87 Metres, Bug Lake Footwall Zone, Detour Gold Trend Project, Quebec investment picks
2014/5/12
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Can M&A save this stock market?
Sign-up for UPDATE: Tech, small-cap stock slide may give way to M&A rush investment picks
NEW YORK (MarketWatch) -- Botox-maker Allergan Inc (AGN) said its board has unanimously rejected the unsolicited bid from Valeant Pharmaceuticals International Inc (VRX), which it said "substantially" undervalues the company.
Sign-up for Allergan board unanimously rejects Valeant bid investment picks
By Hester Plumridge LONDON --
Sign-up for Pfizer details AstraZeneca bid for U.K. lawmakers investment picks
2014/5/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1114220&ProfileId=051205&sourceType=1 NORTH PALM BEACH, FL --
Sign-up for Attitude Drinks and King Supplements Partner to Promote Phase III(R) Recovery Online investment picks
2014/5/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G015582-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/5/12/11G015582/a36f2e47ba4a9147_org-645999135.jpg NEW YORK, NY--(Marketwired - May 12, 2014) - El Maniel International, Inc. (PINKSHEETS: EMLL) is pleased to announce that the Company's insider plans to retire up to two billion shares of its common stock within a 12 months period so as to facilitate merger and acquisition transactions and make our stock more appealing to prospective acquisition targets.
Sign-up for El Maniel International Inc. Announces Plans to Retire up to 20% of Outstanding Shares of Insider investment picks
HOUSTON, May 12, 2014 (GLOBE NEWSWIRE) -- Energy XXI Gulf Coast, Inc. (the "Company"), the operating subsidiary of Energy XXI (Bermuda) Limited ("Energy XXI") (Nasdaq:EXXI) (AIM:EXXI), today announced that it intends, subject to market and other conditions, to offer up to $300 million aggregate principal amount of its senior unsecured notes due 2024 (the "2024 Notes") in a private placement to eligible purchasers (the "Offering"). The Company intends to use a portion of the net proceeds to repay all indebtedness outstanding under its revolving credit facility and the remainder to fund a portion of the cash consideration for Energy XXI's pending acquisition of EPL Oil & Gas, Inc. (the "EPL Acquisition"). If the EPL Acquisition is not consummated, the Company intends to use all of the remaining net proceeds for general corporate purposes.
Sign-up for Energy XXI Gulf Coast, Inc. Announces $300 Million Offering of Senior Notes investment picks
2014/5/12
Online feature makes ordering for large groups fast and easy ANN ARBOR, Mich.
Sign-up for Domino's Pizza® Launches New Online Group Ordering Tool investment picks
http://media.marketwire.com/attachments/201309/66269_187231_ShopHQ_cmyk_URL.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1114379&ProfileId=051205&sourceType=1 MINNEAPOLIS, MN --
Sign-up for ValueVision Mails Letter to Shareholders investment picks
SAN DIEGO, May 12, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) , a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced the initiation of a Phase 2b clinical trial of its lead drug candidate, emricasan, in post-orthotopic liver transplant (POLT) recipients with reestablished liver fibrosis post-transplant as a result of recurrent hepatitis C virus (HCV) infection who have successfully achieved a sustained viral response (SVR) following HCV antiviral therapy (POLT-HCV-SVR). The placebo-controlled, double-blind (open to sponsor) trial is designed to enroll approximately 60 patients at approximately 15 planned U.S. clinical sites.
Sign-up for Conatus Pharmaceuticals Initiates Phase 2b Trial Targeting Fibrosis in Liver Transplant Recipients investment picks
2014/5/12
May 13 webinar presents solutions for enterprises looking to optimize cost-performance and accelerate time-to-value with HP Vertica BURLINGTON, Massachusetts , May 12, 2014 /PRNewswire/ -- Attunity Ltd.
Sign-up for Attunity Hosts Live Webinar on Enabling a Modern Technology Platform for Big Data Analytics investment picks
On Wednesday, May 21, 2014, Xcel Energy (NYSE: XEL) will hold its annual shareholders meeting in Fargo, ND, at 11:00 a.m. Central Time.
Sign-up for Xcel Energy to Webcast Annual Shareholders Meeting investment picks
SAN DIEGO , May 12, 2014 /PRNewswire/ -- Bridgepoint Education (NYSE: BPI) , a provider of postsecondary education services, announced its preliminary results for the first quarter ended March 31, 2014.
Sign-up for Bridgepoint Education Reports Preliminary First Quarter 2014 Results investment picks
2014/5/12
Both the Protocols and Procedures of therapy center inside San Javier Hospital, Guadalajara , are certified by COFEPRIS (Comisión Federal Para la Protección de los Riesgos Sanitarios).  SARASOTA, Fla., May 12, 2014 (GLOBE NEWSWIRE) -- Caribbean International Holdings (Pink Sheets:CIHN) through its subsidiary, Regenerative BioScience, Inc., ("RBS") previously announced on May 7, 2014, that it was opening new treatment locations in Guadalajara, Mexico, and Cabo St Lucas; In an update today, it was announced that the location in Guadalajara was the prestigious San Javier Hospital - Guadalajara.
Sign-up for Caribbean International Holdings (CIHN), Announces Site of 2nd International Treatment Facility; Facility is Approved for Stem Cell Therapies by Mexico's Equivalent of US FDA investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Legg Mason Reports Assets Under Management For April 2014 to Caribbean International Holdings (CIHN), Announces Site of 2nd International Treatment Facility; Facility is Approved for Stem Cell Therapies by Mexico's Equivalent of US FDA
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry